Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human beta-Defensin 3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 4435BD050
This item is not returnable.
View return policy
Description
Measured by its anti-microbial activity against E. coli. Ganz, T. et al. (2003) Nat. Rev. Immunol. 3:710. The ED50 for this effect is 7.5-30 μg/mL.Specifications
P81534 | |
Lyophilized from a 0.2 μm filtered solution in HCl. | |
M.W. (theoretical): 5.2 kDa | |
50 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
DEFB103B | |
Recombinant | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | |
55894 | |
beta-Defensin 3 | |
E. coli-derived human beta-Defensin 3 protein Gly23-Lys67 | |
<0.01 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 500 μg/mL in sterile 4 mM HCl. | |
beta-Defensin 3 |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction